Prothrombotic Responses After Catheter Ablation for Atrial Fibrillation During Uninterrupted Oral Anticoagulant Agent Administration
Prothrombotic Responses After Catheter Ablation for Atrial Fibrillation During Uninterrupted Oral Anticoagulant Agent Administration
复制标题
DOI:
10.1016/j.jacep.2019.09.002
复制
发表时间:
2019-12-01
影响因子:
7
通讯作者:
Murohara, Toyoaki
中科院分区:
文献类型:
--
作者:
Yanagisawa, Satoshi;Inden, Yasuya;Murohara, Toyoaki
OBJECTIVES The aim of this study was to evaluate the extent of changes in prothrombotic responses after catheter ablation for atrial fibrillation (AF) under uninterrupted oral anticoagulant agent (OAC) administration.BACKGROUND Catheter ablation for AF has a potential risk for prothrombotic activation and silent thromboembolic events.METHODS A total of 814 patients (n = 172 [warfarin], n = 153 [dabigatran], n = 134 [rivaroxaban], and n = 301 [apixaban] patients undergoing AF ablation and a control group of 54 patients undergoing non-AF ablation) were included. Uninterrupted OACs were administered during the procedure in patients with AF. Blood samples were collected the day before and 3 days after the procedure.RESULTS At baseline, D-dimer levels were within normal limits (